rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-4-17
|
pubmed:abstractText |
The objective of this study was to correlate the V617F mutation of the JAK2gene and the W515 mutation of the MPLgene in patients with chronic myeloproliferative disease (CMPD) with clinical parameters.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1423-0240
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-5
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19372714-Adult,
pubmed-meshheading:19372714-Aged,
pubmed-meshheading:19372714-Aged, 80 and over,
pubmed-meshheading:19372714-Chronic Disease,
pubmed-meshheading:19372714-Female,
pubmed-meshheading:19372714-Humans,
pubmed-meshheading:19372714-Janus Kinase 2,
pubmed-meshheading:19372714-Male,
pubmed-meshheading:19372714-Middle Aged,
pubmed-meshheading:19372714-Myeloproliferative Disorders,
pubmed-meshheading:19372714-Receptors, Thrombopoietin,
pubmed-meshheading:19372714-Statistics as Topic
|
pubmed:year |
2009
|
pubmed:articleTitle |
Mutations in the JAK2 and MPL genes and their correlation to clinical parameters in patients with chronic myeloproliferative disease.
|
pubmed:affiliation |
Munich Oncology Practice, MVZ Elisenhof, Munich, Germany. p.bojko@onkologie-elisenhof.de
|
pubmed:publicationType |
Journal Article
|